CASI Pharma (CASI) Misses Q3 EPS by 67c

CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.67). Revenue for the quarter came in at $3.07 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Wall Street scrambles to lift Micron price targets ahead of earnings
• ASM International NV (ASM:NA) PT Raised to EUR1,174 at JPMorgan